Screening for complement donors with no or low antibodies to Neisseria meningitidis

Completed

• Conditions: infection.; Meningococci; 10004018

• Registration Number: NL-OMON38256
• Lead Sponsor: Crucell Holland B.V.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Healthy males and females

Exclusion Criteria

Currently taking antibiotics or have taken antibiotics in the 2 weeks preceding blood collection.
Having had any vaccination in the 2 weeks preceding blood collection.
Blood donation outside the limits of Sanquin

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>N.A.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N.A.</p><br>